3 authorised products containing LAROTRECTINIB SULFATE, from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| VITRAKVI 100 mg Capsule, hard EU/1/19/1385/002 |
LAROTRECTINIB SULFATE, LAROTRECTINIB | Bayer AG | — |
| VITRAKVI 20 mg/ml Oral solution EU/1/19/1385/003-004 |
LAROTRECTINIB SULFATE | Bayer AG | — |
| VITRAKVI 25 mg Capsule, hard EU/1/19/1385/001 |
LAROTRECTINIB, LAROTRECTINIB SULFATE | Bayer AG | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.